[Principles of a differentiated immunocorrective therapy].

[Biochemical markers of oxidative stress in different forms and phases of multiple sclerosis]. Zh Nevrol Psikhiatr Im S S Korsakova (2014) 0.75

[Comparative effectiveness of immunomodulators in the therapy of rheumatic heart defects]. Antibiotiki (1984) 0.75

[Comparative effectiveness of immunomodulators in the therapy of bronchopulmonary diseases]. Antibiotiki (1984) 0.75

[The immune status of patients with chronic calculous pyelonephritis and the possibilities for the correction of its disorders]. Urol Nefrol (Mosk) (1991) 0.75

[The immunological disorders in nonspecific lung diseases and the principles for their correction (a lecture)]. Probl Tuberk (1993) 0.75

[Effect of sodium nucleinate on ventricular arrhythmia and blood level of medium molecular weight peptides in an experiment]. Patol Fiziol Eksp Ter (1995) 0.75

[The clinico-immunological aspects of ventricular extrasystole in ischemic heart disease]. Ter Arkh (1992) 0.75

[Effectiveness of immunostimulants in nonspecific ulcerative colitis]. Sov Med (1990) 0.75

[Stimulation of replication and increase in virulence of Shigella growing in RNA-containing media]. Zh Mikrobiol Epidemiol Immunobiol (1983) 0.75

[Immunomodulating therapy of a suppurative infection of the soft tissues]. Khirurgiia (Mosk) (1991) 0.75

[Treatment of secretory otitis media]. Vestn Otorinolaringol (1990) 0.75

[Experimental basis and clinical immunological study of the prevention of staphylococcal infection with anatoxin and sodium nucleinate]. Zh Mikrobiol Epidemiol Immunobiol (1981) 0.75

[Body immunocorrection when vaccination is contraindicated (a clinico-epidemiological validation)]. Voen Med Zh (1992) 0.75

[Effect of sodium nucleinate on the clinical and immunological indicators in infectious-allergic bronchial asthma]. Ter Arkh (1981) 0.75

[Further research on the use of media with Na-RNA for isolating Shigella]. Zh Mikrobiol Epidemiol Immunobiol (1984) 0.75

[Tachyphylaxis]. Usp Sovrem Biol (1977) 0.75

[Beef-extract agar with sodium nucleinate as a medium for storage and stabilization of biological properties of Shigella]. Mikrobiol Zh (1990) 0.75

[Early diagnosis of multiple sclerosis]. Med Tr Prom Ekol (2002) 0.75

[RNA as a modulator of secondary immunological deficiency and dysnucleotidosis]. Antibiotiki (1982) 0.75

[The efficacy of combined immunomodulatory therapy with timoptin and sodium nucleinate in patients with chronic obstructive bronchitis]. Ter Arkh (1989) 0.75

[Characteristics of stomach and duodenal diseases in the framework of high radiation exposure]. Vestn Akad Med Nauk SSSR (1991) 0.75

[The immunological changes in patients with idiopathic ventricular arrhythmias]. Lik Sprava (1992) 0.75

[The immunocorrective therapy of cervix uteri diseases]. Akush Ginekol (Mosk) (1993) 0.75

[Shifts in the human immune system in various disorders as a result of use of immunomodulators]. Fiziol Cheloveka (1995) 0.75

[Efficiency of immune correction in patients with chronic traumatic mandibular osteomyelitis]. Stomatologiia (Mosk) (2001) 0.75

[Combined immunocorrection--a prospective method for treating secondary immunodeficiency]. Vrach Delo (1989) 0.75

[Diagnosis of Campylobacter pylori based on the level of urea in the gastric juice]. Lab Delo (1990) 0.75

[Modulating functions of yeast RNA]. Zh Mikrobiol Epidemiol Immunobiol (1982) 0.75

[Sodium nucleinate in the therapy of chronic lung inflammation complicated by bronchial asthma]. Antibiotiki (1979) 0.75

[Revaccinating effect of yeast RNA]. Mikrobiol Zh (1977) 0.75

[Strengthening the immune response to typhoid vaccine by subcutaneous RNA administration]. Zh Mikrobiol Epidemiol Immunobiol (1977) 0.75

[The development of experimental and clinical research on low-molecular RNA]. Zh Mikrobiol Epidemiol Immunobiol (1987) 0.75

[Correction of secondary immunologic deficiency by using yeast RNA]. Zh Mikrobiol Epidemiol Immunobiol (1984) 0.75

[Effect of RNA nucleotides on Shigella biology]. Zh Mikrobiol Epidemiol Immunobiol (1986) 0.75

[The efficacy of sodium nucleinate in preventing acute respiratory infections in troop units]. Voen Med Zh (1992) 0.75

[Clinical efficacy of various immunomodulating drugs in cirrhosis of the liver]. Vrach Delo (1987) 0.75

[Correction of immunologic disorders in patients with chronic suppurative otitis media]. Vestn Otorinolaringol (1995) 0.75

[Stimulation of the reproduction and growth of pathogenic microorganisms on media with NaRNA]. Lab Delo (1978) 0.75

[Pathogenetic role of RNA in chronic inflammatory and ulcerative diseases of the gastrointestinal tract]. Vrach Delo (1988) 0.75

[The spectrum of medico-biological affects of low molecular weight RNA]. Fiziol Cheloveka (1995) 0.75

[Acute abdominal syndromes in diabetes mellitus]. Klin Med (Mosk) (1989) 0.75

[Detoxifying effect of RNA]. Zh Mikrobiol Epidemiol Immunobiol (1980) 0.75

[Increase in the sensitivity of Shigella to antibiotics]. Antibiot Khimioter (1988) 0.75

[A case of exudative erythema multiforme (a clinico-immunological study)]. Vrach Delo (1991) 0.75

[Immune status of patients with exacerbation of chronic suppurative otitis media and its correction]. Vestn Otorinolaringol (2010) 0.75

[Clinico-immunological aspects of idiopathic ventricular arrhythmia]. Kardiologiia (1992) 0.75

[Further research on the detoxifying effect of RNA]. Zh Mikrobiol Epidemiol Immunobiol (1981) 0.75

[Yeast NaRNA as a stimulator of the virulence, immunogenicity and antigenicity of salmonellae]. Zh Mikrobiol Epidemiol Immunobiol (1979) 0.75

[Immunological disorders and correction of them in surgical patients with atherosclerosis obliterance]. Khirurgiia (Mosk) (2006) 0.75

[Prospective approaches to the evaluation of human immune status]. Lab Delo (1986) 0.75

[Changes in the indices of cellular and humoral immunity in patients with gastrointestinal ulcer]. Vrach Delo (1983) 0.75

[Complications of typhoid vaccination]. Zh Mikrobiol Epidemiol Immunobiol (1977) 0.75

[Sodium nucleinate as a modulator of secondary immunological insufficiency and dysnucleotidosis in nonspecific inflammatory lung diseases]. Ter Arkh (1993) 0.75

[Problem of specific and nonspecific factors in the induction and regulation of immunological reactions]. Zh Mikrobiol Epidemiol Immunobiol (2005) 0.75

[Inhibition of the depressive action of cyclophosphane on immunity and hematopoiesis]. Vopr Onkol (1986) 0.75

[Immunocorrective therapy of patients with rheumatoid arthritis]. Vrach Delo (1990) 0.75

[Treatment with thymogen and myelopid of patients with bronchial asthma]. Klin Med (Mosk) (1995) 0.75

[Principles for assessing and correcting secondary immunological deficiency]. Ter Arkh (1984) 0.75

[The characteristics of the immune status in patients with the Wolff-Parkinson-White syndrome]. Vrach Delo (1991) 0.75

[Diagnostic value of various methods of detection of Campylobacter pylori in patients with gastroduodenal pathology]. Klin Med (Mosk) (1989) 0.75

[Prognostic significance of typical immune reactions in myocardial infarction]. Ter Arkh (2008) 0.75

[The characteristics of the clinical manifestations and treatment of chronic obstructive bronchitis in patients with hepatobiliary system diseases and pseudoallergy]. Klin Med (Mosk) (1998) 0.75

[Typical immune system responses to differential monotherapy with immune-correcting drugs]. Fiziol Cheloveka (2001) 0.75

[Antimicrobial drugs in the treatment of stomach and duodenal diseases associated with Campylobacter pylori]. Klin Med (Mosk) (1989) 0.75

Biodynamic effects of RNA. J Hyg Epidemiol Microbiol Immunol (1981) 0.75

[Typical responses of the immune system in pathological processes]. Fiziol Cheloveka (2001) 0.75

[Increasing the non-specific resistance of animals to pathogenic E. coli with preparations of RNA]. Zh Mikrobiol Epidemiol Immunobiol (1977) 0.75

[The possible significance of immunological disorders in the pathogenesis of paroxysmal supraventricular tachycardia in patients with the Wolff-Parkinson-White syndrome]. Lik Sprava (1992) 0.75

[Blood group-dependent efficiency of immunological correction in patients with chronic purulent otitis media]. Vestn Otorinolaringol (1998) 0.75

[Further research on an experimental justification for the emergency prophylaxis of typhoid]. Zh Mikrobiol Epidemiol Immunobiol (1975) 0.75

[The immunological reactivity of healthy persons of different ages and the ABO system antigens]. Fiziol Cheloveka (2000) 0.75

[The use of millimeter-range electromagnetic radiation for treating peptic ulcer]. Vrach Delo (1990) 0.75

[Secondary immunodeficiency states and their correction with sodium nucleinate]. Ter Arkh (1982) 0.75

[A deficient T-cell count and its elimination during the treatment and prevention of infections]. Zh Mikrobiol Epidemiol Immunobiol (1996) 0.75

[The therapeutic efficacy of sodium nucleinate and monoribonucleotides based on keratoconjunctival test data]. Zh Mikrobiol Epidemiol Immunobiol (1994) 0.75

[Relation of immunity indices with clinical manifestations of peptic ulcer]. Vrach Delo (1983) 0.75

[The relationship of immunological reactivity to blood groups]. Vrach Delo (1990) 0.75

[Immune reactivity and environmental factors]. Fiziol Cheloveka (1998) 0.75

[Non-alternative elements in the pathogenesis of peptic ulcer and their modulation with sodium nucleinate]. Ter Arkh (1983) 0.75

[Stimulation of the multiplication of anaerobes in liver bouillon with sodium nucleinate]. Zh Mikrobiol Epidemiol Immunobiol (1983) 0.75

[Methods for assessing the efficacy of immunocorrection]. Zh Mikrobiol Epidemiol Immunobiol (1997) 0.75

[Additional methods of assessment of immune status]. Klin Lab Diagn (1994) 0.75

[Prophylactic immunocorrection with sodium nucleinate]. Med Tr Prom Ekol (1995) 0.75

[The effect of sodium nucleinate on allergic reactions]. Patol Fiziol Eksp Ter (1990) 0.75

[Available methods of evaluation and correction of immune disorders in patients]. Klin Lab Diagn (1997) 0.75

[State of the kallikrein-kinin system in thyrotoxicosis]. Vrach Delo (1980) 0.75

[Pathologico-anatomic characteristics of experimental myocardial infarct in exposure to low-frequency low-intensity electromagnetic fields]. Probl Kosm Biol (1982) 0.75

[Combined immunomodulating therapy of chronic diseases of the respiratory system]. Ter Arkh (1987) 0.75

[Immunopathologic disorders in chronic nonspecific inflammatory intestinal diseases]. Klin Med (Mosk) (1989) 0.75

[Stimulation of primary and secondary immune responses with yeast NaRNA]. Mikrobiol Zh (1980) 0.75

[Clinical efficacy of immunostimulating drugs in treatment of purulent infections]. Khirurgiia (Mosk) (2011) 0.75